Word: roussel
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...activists have fought to introduce it to the U.S. as the first alternative to surgical abortion. The FDA under President Bush banned its import in 1989, citing safety concerns. On his third day in office, President Clinton lifted the ban and ordered the FDA to begin safety testing. Developer Roussel Uclaf, meanwhile, sick of getting hammered by both sides, donated U.S. patent rights for mifepristone to the Population Council, a nonprofit reproductive-rights group founded 50 years ago by John D. Rockefeller. The council had to steer the drug through U.S. trials, file the applications for approval, weather the political...
Fears of antiabortion protests kept Roussel Uclaf, the French company that developed mifepristone, from trying to enter the American market. Instead, the company donated rights to the drug to the Population Council, a New York City-based nonprofit research organization. The council conducted the clinical trial of mifepristone, but needed a drug-company partner to handle manufacturing, advertising and distribution. Again, fears of protest--or worse--intervened, with drug behemoths refusing to touch the controversial pill. The council spent a year searching before it chose Danco, a company started expressly to handle mifepristone...
...French professor Etienne-Emile Baulieu and researchers from Roussel Uclaf synthesize RU 486 (mifepristone...
...Roussel Uclaf reports first successful human testing...
...Instead, Roussel-UCLAF, which holds the pill's 20-year-old patent, granted sole American distribution rights to the Population Council, a nonprofit organization specializing in reproductive issues, with the understanding the group would conduct clinical trials and find a manufacturer for the drug. And after six years of research and more than a few last-minute panic attacks from would-be manufacturing companies, the moment has arrived. The Population Council concluded a hugely successful drug trial in which 92 percent of the participants achieved successful medical abortions - the remaining 8 percent required surgical intervention to complete the procedure. Within...